印度的AYUSH药品出口增长了6.11%,达到2024-25年的688.89亿美元,这得益于与阿曼和新西兰的新贸易交易以及Ayush质量标记。 India’s AYUSH medicine exports rose 6.11% to $688.89 million in 2024–25, aided by new trade deals with Oman and New Zealand and the Ayush Quality Mark.

2024年12月完成的与阿曼和新西兰的贸易协定正式承认了印度的传统医药系统,称为AYUSH,其中包括关于保健服务和传统医学的专门章节。 India’s traditional medicine systems, known as AYUSH, gained formal recognition in trade agreements with Oman and New Zealand, finalized in December 2024, including dedicated chapters on health services and traditional medicine. 在阿尤什出口促进理事会在全球推广、质量标准和贸易促进方面的努力的推动下,Ayush出口促进理事会和草药产品出口在2024-25年期间增长了6.11%,达到6.8889亿美元。 Exports of AYUSH and herbal products rose 6.11% to $688.89 million in 2024–25, driven by the Ayush Export Promotion Council’s efforts in global outreach, quality standards, and trade promotion. 该理事会是为支持出口商和确保遵守规定而设立的,负责管理莫迪总理在2025年世卫组织首脑会议上推出的Ayush质量标记,从而提高了国际信誉。 The council, established to support exporters and ensure compliance, manages the Ayush Quality Mark, launched by Prime Minister Modi at the 2025 WHO Summit, enhancing international credibility. 这些发展动态与印度的Atmanirbhar Bharat和Make India倡议相一致,促进了该部门的全球存在。 These developments align with India’s Atmanirbhar Bharat and Make in India initiatives, boosting the sector’s global presence.